Generic, Branded Generic & Proprietary Medicinal Products - Group 18
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £1,800,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | Northern Ireland |
| Deadline | 14 Dec 2025 |
| Procedure | selective |
| OCID | ocds-h6vhtk-0437e0 |
Awards (134)
This procurement was awarded to 134 suppliers. Values shown are per-award; the notice total is £1,800,000,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Abbvie Ltd shared | · | · | active |
| AbbVie Ltd shared | · | · | active |
| Accord Uk Ltd shared | · | · | active |
| Accord UK Ltd shared | · | · | active |
| Accord-UK Ltd shared | · | · | active |
| AGB Pharma shared | · | · | active |
| Aguettant Ltd shared | · | · | active |
| Alliance shared | · | · | active |
| Amarox Ltd shared | · | · | active |
| AOP Orphan Ltd shared | · | · | active |
| Aspire shared | · | · | active |
| Aspire Pharma Ltd shared | · | · | active |
| Astrazeneca shared | · | · | active |
| Aventis Pharma shared | · | · | active |
| Aventis Pharma Ltd shared | · | · | active |
| Baxter shared | · | · | active |
| Baxter Healthcare Ltd shared | · | · | active |
| Bayer shared | · | · | active |
| Bayer PLC shared | · | · | active |
| B Braun shared | · | · | active |
| B Braun Medical Ltd shared | · | · | active |
| B Braun Medical Ltd UK shared | · | · | active |
| Beaumont Pharma Ltd shared | · | · | active |
| Biogen IDEC Ltd shared | · | · | active |
| Bowmed shared | · | · | active |
| Bowmed Ibisqus Ltd shared | · | · | active |
| Chiesi Ltd shared | · | · | active |
| Colonis shared | · | · | active |
| Colonis Pharma Ltd shared | · | · | active |
| Day Lewis Medical Ltd shared | · | · | active |
| Desitin Pharma Ltd shared | · | · | active |
| DR. FALK PHARMA UK LIMITED shared | · | · | active |
| Dr Falk Pharma Uk Ltd shared | · | · | active |
| Drugsrus Ltd shared | · | · | active |
| Drugsruus shared | · | · | active |
| Esteve Pharmaceuticals Limited shared | · | · | active |
| Esteve Pharmaceuticals Ltd shared | · | · | active |
| Fannin shared | · | · | active |
| FERRING PHARMACEUTICALS LIMITED shared | · | · | active |
| Ferring Pharmaceuticals Ltd shared | · | · | active |
| Flexipharm Austrading Ltd shared | · | · | active |
| Flynn shared | · | · | active |
| Flynn Pharma Ltd shared | · | · | active |
| Focus Pharmaceuticals Limited shared | · | · | active |
| Focus Pharmaceuticals Ltd shared | · | · | active |
| Fresenius Kabi shared | · | · | active |
| Fresenius Kabi Limited shared | · | · | active |
| Fresenius Kabi Ltd shared | · | · | active |
| Galen shared | · | · | active |
| GlaxoSmithKline shared | · | · | active |
| Glaxosmithkline Ltd shared | · | · | active |
| GLAXOSMITHKLINE UK LTD shared | · | · | active |
| GLENMARK PHARMACEUTICALS EUROPE LIMITED shared | · | · | active |
| Glenmark Pharmaceuticals Europe Ltd shared | · | · | active |
| GL Pharma UK Ltd shared | · | · | active |
| Grunenthal shared | · | · | active |
| Hameln Pharma Ltd shared | · | · | active |
| HAMELN PHARMA LTD shared | · | · | active |
| Hamlen Pharma Ltd shared | · | · | active |
| IBSA PHARMA LIMITED shared | · | · | active |
| Infectopharm shared | · | · | active |
| Infectopharm Ltd shared | · | · | active |
| Janssen-Cilag Limited shared | · | · | active |
| JANSSEN-CILAG LIMITED shared | · | · | active |
| Janssen Cilag Ltd shared | · | · | active |
| Kent Pharma Ltd shared | · | · | active |
| Kent Pharma Uk Ltd shared | · | · | active |
| Kent Pharma UK Ltd shared | · | · | active |
| Kyowa Kirin International UK New Co Ltd shared | · | · | active |
| Kyowa Kirin Ltd shared | · | · | active |
| Lupin Healthcare (UK) Limited shared | · | · | active |
| Lupin Healthcare UK Ltd shared | · | · | active |
| Macarthy's Laboratories Ltd T/A Martindale Pharma shared | · | · | active |
| Macarthys Laboratories Ltd T/A Martindale Pharma shared | · | · | active |
| MACARTHYS LABORATORIES LTD T/A MARTINDALE PHARMA shared | · | · | active |
| Martindale Pharma shared | · | · | active |
| Medac Pharma LLP shared | · | · | active |
| MEDAC PHARMA LLP shared | · | · | active |
| MEDITEQ HEALTHCARE SOLUTIONS LIMITED shared | · | · | active |
| MERCK SHARP & DOHME (UK) LIMITED shared | · | · | active |
| Merck Sharpe Dohme shared | · | · | active |
| Mercury Pharmaceuticals Lt shared | · | · | active |
| Mercury Pharmaceuticals Ltd shared | · | · | active |
| MORNINGSIDE PHARMACEUTICALS LIMITED shared | · | · | active |
| Morningside Pharmaceuticals Ltd shared | · | · | active |
| Napp shared | · | · | active |
| Napp Pharmaceuticals Ltd shared | · | · | active |
| Neon Healthcare Ltd shared | · | · | active |
| NEON HEALTHCARE LTD shared | · | · | active |
| Neuraxpharm shared | · | · | active |
| Neuraxpharm Ltd shared | · | · | active |
| Neuraxpharm Uk Ltd shared | · | · | active |
| Novartis Pharmaceuticals UK Ltd shared | · | · | active |
| NOVUMGEN LIMITED shared | · | · | active |
| Pfizer Ltd shared | · | · | active |
| PHARMACOSMOS UK LTD shared | · | · | active |
| PROVEPHARM UK LTD shared | · | · | active |
| RAYNER PHARMACEUTICALS LIMITED shared | · | · | active |
| Recordati Pharmaceuticals Ltd shared | · | · | active |
| Roche shared | · | · | active |
| Roche Products Ltd shared | · | · | active |
| ROCHE PRODUCTS LTD shared | · | · | active |
| Rosemont Pharmaceuticals Ltd shared | · | · | active |
| ROSEMONT PHARMACEUTICALS LTD shared | · | · | active |
| Sandoz Limited shared | · | · | active |
| SANDOZ LIMITED shared | · | · | active |
| Sandoz Ltd shared | · | · | active |
| SEACROSS PHARMACEUTICALS LTD shared | · | · | active |
| STIRLING ANGLIAN PHARMACEUTICALS LIMITED shared | · | · | active |
| Stirling Anglian Pharmaceuticals Ltd shared | · | · | active |
| Sun Pharma UK shared | · | · | active |
| Sun Pharma UK Ltd shared | · | · | active |
| SWEDISH ORPHAN BIOVITRUM LTD shared | · | · | active |
| Takeda UK Ltd shared | · | · | active |
| Techdow Pharma England Ltd shared | · | · | active |
| Teva UK Ltd shared | · | · | active |
| THORNTON & ROSS LIMITED shared | · | · | active |
| Thornton & Ross Ltd shared | · | · | active |
| TILLOMED LABORATORIES LIMITED shared | · | · | active |
| Tillomed Laboratories Ltd shared | · | · | active |
| Tillotts Pharma UK Ltd shared | · | · | active |
| Tilomed shared | · | · | active |
| Tilotts shared | · | · | active |
| Torbay Pharmaceuticals shared | · | · | active |
| Torbay Pharmaceuticals Ltd shared | · | · | active |
| Typharm shared | · | · | active |
| Typharm Ltd shared | · | · | active |
| Viatris shared | · | · | active |
| Viatris UK Healthcare Ltd shared | · | · | active |
| Vifor Pharma UK Ltd shared | · | · | active |
| Wockhardt UK Holdings Ltd shared | · | · | active |
| WOCKHARDT UK HOLDINGS LTD shared | · | · | active |
| Wockhardt UK Ltd shared | · | · | active |
| Zentiva Pharma UK Ltd shared | · | · | active |
description
Generic, Branded Generic & Proprietary Medicinal Products - Group 18 (6345404)
notice history
10 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 7 Feb 2024 | Contract notice (F02) | Earlier regulations | 004040-2024 |
| 14 Feb 2024 | Contract award notice (F03) | Earlier regulations | 004867-2024 |
| 15 Aug 2024 | Contract award notice (F03) | Earlier regulations | 025898-2024 |
| 16 Aug 2024 | Corrigendum (F14) | Earlier regulations | 026065-2024 |
| 16 Aug 2024 | Corrigendum (F14) | Earlier regulations | 026069-2024 |
| 24 Jan 2025 | Contract award notice (F03) | Earlier regulations | 002567-2025 |
| 1 Jul 2025 | Corrigendum (F14) | Earlier regulations | 036462-2025 |
| 21 Aug 2025 | Contract award notice (F03) | Earlier regulations | 050474-2025 |
| 12 Jan 2026 | Contract award notice (F03) | Earlier regulations | 002118-2026 |
| 3 Jul 2026 | Contract award notice (F03) | Earlier regulations | 062803-2026 |
more from Regional Business Services Organisation, Procurement and Logistics Service
- Pre-Market Engagement - CAWT PEACEPLUS EASY Project: Early Intervention Support for Children, Young People and Families presenting with Neurodevelopmental Needs (SHSCT Area) · 20 Jul 2026
- Seasonal Influenza Vaccines 2026/2027 · 21 May 2026
- Pre-Market Engagement - CAWT PEACEPLUS Community Connections and Wellbeing project (CCWP) – Delivery of Psychosocial Activities and Community Supports (WHSCT and SHSCT Areas) · 15 May 2026
- Agency Workers – Medical and Dental · £345,000,000 · 28 Apr 2026
- Pre-Market Engagement - CAWT PEACEPLUS Healthier Futures Project - Community-Based Early Intervention Health Improvement Programmes (WHSCT & SHSCT Areas) · 27 Apr 2026
- Total Cellular Pathology Solution - 2805386 · £65,000,000 · 4 Mar 2026
- Newborn Screening Equipment and Reagents for Congenital Hypothyroidism (CHT), Cystic Fibrosis (CF) and sample puncher - 5729591 · £1,800,000 · 23 Oct 2025
- PROFESSIONAL USE POINT OF CARE TESTING (POCT) BLOOD GLUCOSE AND KETONE MONITORING SYSTEMS · £26,686,088 · 16 Oct 2025
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
- LW158 IMP Support (FAME) · Liverpool School of Tropical Medicine · £0
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.